75 Years of Exceptional Care and Innovation | Celebrate with Zoom backgrounds, email signatures and more!

Amandine Lejeune

Amandine Lejeune

Associate Professor

Surgical & Radiological Sciences


Education
2000, BS, Lycée Albert Calmette, Nice, France
2006, National Veterinary School of Toulouse, Toulouse, France
2007, National Veterinary Schoolof Maisons-Alfort, Maisons-Alfort, France
2008, DVM, National Veterinary Schoolof Maisons-Alfort, Maisons-Alfort, France
2009, Tufts University, North Grafton, MA
2010, Ontario Veterinary College (OVC), University of Guelph, Guelph,ON
2013, University of California Davis, Davs, CA
2013, DACVIM, American College of Veterinary Internal MedicineSpecialty of Oncology,
Active Research Grants
Principal Investigator, A pilot study to determine the safety and efficacy of CBD oil use during chemotherapy, (Principal Investigator), Ellevet Science
Principal Investigator, Evaluation of pharmacokinetics and toxicity of paclitaxel administered subcutaneously in tumor bearing dogs – a pilot study, (Principal Investigator), UF SACS
Co-Investigator, The efficacy of acupuncture and Chinese herbal medicine on survival and quality of life in dogs with multicentric lymphoma receiving CHOP chemotherapy: a randomized controlled trial, Dr. Huisheng Xie (Principal Investigator), American Holistic Veterinary Medical Foundation
Most Recent Five Book Chapters
2016 Lejeune A, Schaer M, Gashen F : Case of a feline hyperaldosteronism, Schaer M, Gashen F, (ed), Clinical Medicine of the Dog and Cat, 3rd Edition, Boca Raton, FL. 1109-1110.
Ten Recent Publications

2020
Fox-Alvarez S, Shiomitsu K, Lejeune AT, Szivek A, Kubicek L
Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas.

2019
Lanaux T, Lejeune A, Eide, Estrada A
The Opioid Crisis: Responsibilities of the Veterinary Profession

2019
Reckelhoff CR, Lejeune A, Thompson PM, Shiomitsu K
In vitro effects of the chemotherapy agent water-soluble micellar paclitaxel (Paccal Vet) on canine hemangiosarcoma cell lines.

2019
Hutchison S, Sahay B, de Mello SC, Sayour EJ, Lejeune A, Szivek A, Livaccari AM, Fox-Alvarez S, Salute M, Powers L, Milner RJ
Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy.

2018
Speas AL, Lyles SE, Wirth KA, Fahey CE, Kow K, Lejeune AT, Milner RJ
Plasma ammonia concentration after Lasparaginase therapy in 27 dogs with high-grade lymphoma or leukemia

2018
Miller KB, Lejeune A, Regan R, Szivek A, Kow K
Suspected Carboplatin Extravasation Reactions in Seven Dogs.

2018
Harding K, Bergman N, Smith A, Lindley S, Szivek A, Milner R, Brawner W, Lejeune A
Response rate to a single dose of vinblastine administered to dogs with treatment-naive multicentric lymphoma.

2017
Lejeune A
Clinical approach to canine and feline oncology Title of review article (translation) : Review article on staging recommendations for canine and feline patients

2017
Smith AA, Lejeune A, Kow K, Milner RJ, Souza CH
Clinical Response and Adverse Event Profile of Bleomycin Chemotherapy for Canine Multicentric Lymphoma.

2017
Talbott JL, Boston SE, Milner RJ, Lejeune A, Souza CH, Kow K, Bacon NJ, Hernandez JA
Retrospective Evaluation of Whole Body Computed Tomography for Tumor Staging in Dogs with Primary Appendicular Osteosarcoma.